Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Melanoma 3Lung Neoplasms 3Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Radiation Injuries 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Hematologic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Bites and Stings 1

Interventions

Radiotherapy 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 7Cyclophosphamide 7Busulfan 7Whole-Body Irradiation 6Melphalan 6Radiofrequency Ablation 5Mycophenolic Acid 5Filgrastim 5Antilymphocyte Serum 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Methotrexate 4Etoposide 4Drug Therapy 4Cisplatin 4fludarabine 3Radiosurgery 3Injections 3Hepatectomy 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2lenvatinib 2Vinblastine 2Videotape Recording 2Thiotepa 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recurrence × Immunotherapy × Clear all
NCT05059782 2021-09-28

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Xi'an Jiaotong University

Phase NA Unknown
150 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡